9
Views
7
CrossRef citations to date
0
Altmetric
Research Article

The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

Pages 353-357 | Published online: 10 Jul 2009

References

  • Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Meternskotter T, Eggers C, Stellbrink H-J (1998). Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12(11): 1149–1154.
  • Berger JR, Major EO (1999). Progressive multifocal leukoen-cephalopathy. Sem Neurol 19(2): 193–200.
  • Cinque P, Casari S (1998). Progressive multifocal leukoen-cephalopathy, HIV, and highly active antiretroviral ther-apy (Letter). New Eng J. Med 339(12): 848–849.
  • Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART im-proves prognosis in HIV-associated progressive multifo-cal leukoencephalopathy. Neurology 52(3): 623–625.
  • De Luca A, Ammassari A, Cingolani A, Giancola ML, Antinori A (1998). Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretrovi-ral therapy [letter] AIDS 12(14): 1937–1938.
  • De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG, Gentile M, Cingolani A, Murri R, Liuzzi G, Monforte AD, Aninori A (2000). The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clin-ical outcome of patients with AIDS-associated progres-sive multifocal leukoencephalopathy. I Infect Dis 182: 1077–1083.
  • Dworkin MS, Wan PC, Hanson DL, Jones JL (1999). Progressive multifoc al leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. I Infect Dis 180: 621–625.
  • Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla, Dike W, Lazzrin A, Weber, Cinque P (2000). Highly active an-tiretroviral therapy and progressive multifocal leukoen-cephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.
  • Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yiannoutsos C, Major E, Millar L, Timpone J (1998). Failure of Cytara-bine in progressive multifocal leukoencephalopathy as-sociated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team [see comments]. New Engl J Med 338(19): 1345–1351.
  • Happe S, Besselmann M, Mathej a P, Rickert CH, Schuierer G, Reichelt D, Husstedt I-W (2000). Therapy of pro-gressive multifocal leukoencephalopathy (PML) in AIDS with cidofovir (VistideC)). Nervenarzt 70: 935–943.
  • Happe S, Liinenborg N, Rickert CH, Heese C, Reichelt D, Schuierer G, Schul C, Husstedt IW (2000). Progressive multifocal leukoencephalopathy in 17 AIDS patients. Nervenarzt 71: 96–104.
  • Huang SS, Skolasky RL, Dal Pan GJ, Royal W III, McArthur JC (1998). Survival prolongation in HIV-associated pro-gressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. I NeuroVirol 4(3): 324–332.
  • Miralles P, Berenguer J, Garcea de Viedma D, Padilla B, Cosin J, L6pez-Bernaldo de Quir6s JC, Munoz L, Moreno S, Bouza E (1998). Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467–2472.
  • Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1999). Progressive multifocal leukoen-cephalopathy in patients with AIDS receiving highly ac-tive antiretroviral therapy. Clin Infect Dis 28(5): 1152–1154.
  • Taoufik Y, Delfraissy JF, Gasnault J (2000). Highly active antiretroviral therapy does not improve survival of pa-tients with high JC virus load in the cerebrospinalfluid at progressive multifocal leukoencephalopathy diagnosis [letter] AIDS 14(6): 758–759.
  • Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boue F, Billaud R, Costagliola D (1999). Survival improvement of AIDS-related progressive multifocal leukoen-cephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS 13: 1881–1887.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.